Jeffrey A. Schwaneke is Chief Financial Officer of agilon health, inc.. Currently has a direct ownership of 723,930 shares of AGL, which is worth approximately $2.37 Million. The most recent transaction as insider was on Jul 01, 2024, when has been sold 659,880 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 724K
1030.26% 3M change
7416.66% 12M change
Total Value Held $2.37 Million

Jeffrey A. Schwaneke Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2024
BUY
Grant, award, or other acquisition
-
659,880 Added 47.69%
723,930 Common Stock
May 29 2024
BUY
Grant, award, or other acquisition
-
32,119 Added 33.4%
64,050 Common Stock
Nov 29 2023
BUY
Open market or private purchase
$250,206 $11.22 p/Share
22,300 Added 41.12%
31,931 Common Stock
Apr 14 2023
BUY
Grant, award, or other acquisition
-
5,622 Added 36.86%
9,631 Common Stock
Aug 10 2022
BUY
Grant, award, or other acquisition
-
4,009 Added 50.0%
4,009 Common Stock

Also insider at

CNC
CENTENE CORP Healthcare
JAS

Jeffrey A. Schwaneke

Chief Financial Officer
Austin, TX

Track Institutional and Insider Activities on AGL

Follow agilon health, inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGL shares.

Notify only if

Insider Trading

Get notified when an Agilon Health, Inc. insider buys or sells AGL shares.

Notify only if

News

Receive news related to agilon health, inc.

Track Activities on AGL